The hydrogel itself is a hybrid of two different polymers: a seaweed extract called alginate that is used to thicken food, and polyacrylamide, which is the main material in soft contact lenses. When these relatively weak polymers become entangled with each other, they create a molecular network that demonstrates unprecedented toughness and resilience for a hydrogel material — on par with the body’s natural cartilage. When combined with an adhesive layer containing positively charged polymer molecules (chitosan), the resulting hybrid material is able to bind to tissues stronger than any other available adhesive, stretch up to 20 times its initial length, and attach to wet tissue surfaces undergoing dynamic movement (e.g., a beating heart).
Studies of the hydrogel adhesive demonstrated that it is capable of withstanding three times the amount of tension that disrupts the best current medical adhesives, maintaining its stability and adhesion when implanted into rats for two weeks, and sealing a hole in a pig heart that was subjected to tens of thousands of cycles of pumping. Additionally, it caused no tissue damage or adhesions to surrounding tissues when applied to liver hemorrhages in mice.
The hydrogel adhesive has numerous potential applications in the medical field, either as a patch that can be cut to desired size and applied to tissues such as bone, cartilage, tendon, or pleura, or as an injectable solution for deeper injuries. It can also be used to attach medical devices to their target structures, such as an actuator to support heart function. While the current iteration is designed to be a permanent structure, it could be made to biodegrade over time as the body heals.
This research was funded by the Wyss Institute at Harvard University, NSF, Materials Research Science & Engineering Centers at Harvard University, NIH, Science Foundation Ireland, Tsinghua University, as well as a Marie Curie International Outgoing Fellowship.
To read the full story, visit the Wyss Institute’s website.